SUMMARY The respiratory and arousal responses to mild hypoxia during quiet sleep were studied using inductive plethysmography and transcutaneous gas electrodes in 11 apnoeic infants before and after the administration of oral theophylline (3 mg/kg). Theophylline changed the ventilatory response to a more biphasic pattern-that is, ventilation decreased after an initial increase. The relative ventilatory slope (defined as the decrease in transcutaneous carbon dioxide tension (PCO2) in relation to the fall in transcutaneous oxygen tension (P02)) decreased significantly after theophylline. Four infants were roused during hypoxia before theophylline administration compared with none after treatment. Theophylline abolished the periodic breathing induced by hypoxia in one of six infants. These findings suggest that methylxanthines may not, as previously thought, enhance the respiratory drive during hypoxia.
Methylxanthine derivatives are widely used as respiratory stimulants both in low birthweight infants with idiopathic apnoea and in those with apnoea of infancy. These compounds increase the respiratory drive and reduce the number of apnoeic episodes both in premature'2 and older apnoeic infants.3 4 Theophylline has also been assumed to increase the ventilatory and arousal responsiveness to hypoxia in babies with apnoea of infancy.3 Experimental studies in newborn animals, however, have shown contradictory results.5 6 In man investigations have so far only been performed in adults.7 8 The aim of this study was to investigate whether theophylline given before a hypoxic challenge increased the ventilatory and arousal responsiveness. Two hypoxic challenges, one before and one after the administration of theophylline, were performed during the same night in 11 infants with severe apnoeic events associated with sleep.
Patients and methods
The study was approved by the local ethical committee and informed parental consent was obtained in all cases. Seven boys and four girls who had had a potentially life threatening apnoeic episode were entered in the study. Their median age at the time of the recording was 10 weeks (range 3-21). These 11 infants were part of a larger group of apnoeic infants recently evaluated in a prospective collaborative study.9
The respiratory investigations comprised a 10 minute hypoxic challenge with 15% oxygen in nitrogen. A warmed and humidified hypoxic gas mixture was delivered at a rate of 6-8 I/minute through a 10 1 plastic hood covering the head and neck. The tests were performed in standardised conditions (the environmental temperature was 24°C, and the lights were dimmed) during quiet sleep.10 The control test was carried out between 9 and 11 pm. The infants were lying prone and after a five minute stable control period in air the hypoxic gas mixture was delivered for 10 minutes. The test was repeated between 0 and 2 am, about one hour after administration of an oral dose of theophylline cholinate 3 mg/kg.
Recordings during uninterrupted natural sleep were a matter of prime concern in the investigation; to avoid the disturbance of blood sampling plasma theophylline concentrations were not determined. Periodic breathing was defined as three or more regularly recurring episodes of respiratory arrests of more than 3 seconds in duration interrupted by periods of regular breathing of less than 20 seconds. Arousal was defined as crying and opening of the eyes or signs of discomfort and gross body movements for at least 20 seconds. The tcPO2 and tcPCO2 values of the last minute prior to the test were used as baseline measurements.
The respiratory data of each baby before and after the administration of theophylline were compared by Student's t test, repeated measures design. Fisher's exact test was used to assess the significance of differences in incidence of arousal and periodic breathing before and after treatment. Regression analysis was used to determine slopes and relations.
Results
Most infants increased their ventilation about 20% over the control period in response to the hypoxic provocation and sustained this increase throughout the 10 minutes of hypoxia (fig 2) . After administration of theophylline a similar increase in ventilation was observed. The rise in ventilation, however, was not sustained to the same extent as before treatment (fig 2) . Although the ventilatory response to hypoxia varied considerably among individual babies, the altered response pattern after theophylline administration was a consistent observation.
The effect of theophylline on tcPO2 and tcPCO2 measurements in a six week old girl is shown in fig 1; her response pattern was representative of the whole group of infants. After theophylline adminis- tration there was a significant increase in mean (SD) baseline tcPO2 tension (1-8 (1.6) kPa; p<0.005) and a significant decrease in mean (SD) baseline tcPCO2 tension (0-5 (0-4) kPa; p<0-0009). The relative ventilatory slope (non-dimensional index) decreased on average 1-6 (1-5) (p<0-02) after theophylline, indicating a relative decrease in ventilation.
The mean rate of decrease of tcPO2 during the hypoxic challenge was not significantly affected by theophylline. The average decrease (here expressed in logarithmic units as -lge kPa/minute) was -0-059 (0.028) before and -0-064 (0-028) after treatment. The mean lowest tcPO2 tension remained unchanged, being 5-2 (1-4) kPa before and 5-5 (1-5) kPa after theophylline administration.
All infants breathed regularly during the control period. Theophylline abolished periodic breathing induced by hypoxia in only one of the six infants who had this breathing pattern before treatment. Four infants were roused before theophylline administration compared with none after treatment.
Discussion
The two main findings of this study are that theophylline does not increase ventilatory responsiveness to hypoxia, and it has no consistent effects on the periodic breathing induced by hypoxia. Furthermore, arousal responsiveness seemed to decrease after treatment with theophylline. These effects of theophylline during hypoxia contrast strongly with its well known stimulatory effects on respiration during air breathing.
After theophylline administration baseline tcPO2 tension increased and baseline tcPCO2 tension decreased significantly. This suggests an increase in resting ventilation, which confirms previous observations.' Because tcPO2 tensions were higher and those of tcPCO2 lower after theophylline adminstration, a less pronouced immediate ventilatory response to hypoxia could be expected due to the lower chemoreceptor stimulation, both peripherally and centrally. This was not found, as the degree of the initial ventilatory response was not affected by theophylline. The immediate response to hypoxia is largely mediated by carotid body chemoreceptor activity, and therefore the unchanged responsiveness (in spite of higher baseline tcPO2 tensions) may suggest that theophylline has some stimulatory effects on peripheral chemoreceptors. 12 The hypoxic respiratory responsiveness was estimated by analysing the changes in tcPCO2 in relation to the fall in tcPO2. Measurements of pulmonary ventilation alone may not be adequate to interpret the hypoxic ventilatory response in infants = .,I In healthy adults aminophylline has been reported to increase hypoxic ventilatory responsiveness, but only when alveolar PCO2 was raised to pretreatment concentrations.7 8 It was therefore concluded that methylxanthines increase hypoxic responsiveness, although this effect was masked by the relative hypocapnoea produced by these compounds. Raising the PCO2 to concentrations prevailing before theophylline administration, however, will stimulate breathing both by peripheral and central mechanisms. 23 This complex interaction may not allow definite conclusions to be drawn on the responsiveness to hypoxia.
The results of this study do not contradict the view that methylxanthines may diminish the risk of sleep related apnoeic episodes by increasing baseline oxygen concentrations. They do, however, suggest that the concept of increasing hypoxic responsiveness by treatment with theophylline is questionable. To determine whether the observed decrease in the ventilatory and arousal response is of clinical importance needs further evaluation. Nevertheless, it is suggested that methylxanthines should be used with some caution in babies with apnoea of infancy.
